The paper-based card separates plasma from whole-blood samples, allowing them to be used for HIV viral load testing.

One ACED project is focused on developing biomarkers for the early detection of ovarian cancer, with the goal of commercializing any resulting tests.

The company has received certification under Europe's In Vitro Diagnostic Regulation for a number of tests recently.

The company will use the lab to run its PromarkerD proteomic blood test for identifying individuals at risk of diabetes-related chronic kidney disease.

The firm's Qlucore Diagnostics 1.0 for BCP-ALL software is used to aid the diagnosis and treatment of B-cell precursor acute lymphoblastic leukemia.

The group recently published a case-control study showing high sensitivity and specificity, with little drop in early-stage disease, compared to late-stage cancer.

NEW YORK – After acquiring Lucira Health in a bankruptcy auction in 2023, Pfizer has decided to shut down the business, a Pfizer spokesperson told GenomeWeb.